https://www.selleckchem.com/products/jdq443.html
Primary sarcomas of the chest wall are rare aggressive tumors. Surgery is part of the multimodal treatment. We describe our institutional patient cohort and evaluate prognostic factors. All patients who had curative intent surgery for primary chest wall sarcoma from 2004 to 2019 were retrospectively reviewed. Impact on survival-calculated from the date of surgery until last follow-up- was assessed for the following variables age, gender, type of resection, size, grading, stage, completeness of resection, and neoadjuvant and adjuvant ther
Like
Comment
Share
